MedaSorb Appoints Dr. Edward R. Jones, MD, MBA to Board of Directors (RedNova)
MedaSorb Technologies Corporation (OTCBB: MSBT) announced today the appointment of Dr. Edward R. Jones, MD, MBA to its Board of Directors, effective April 9, 2007. Dr.

SmallCap Sentinel: The Mark of Progress (RedNova)
IRVINE, Calif., April 9, 2007 (PRIME NEWSWIRE) -- "As most small cap investors are neither medical doctors or biotechnology scientists, a critical element in the evaluation of a company is the progress made toward Food and Drug Administration approvals," stated SmallCap Sentinel analyst D.R.

Oscient Pharmaceuticals Provides Preliminary Revenue Results for the First Quarter of 2007 (Business Wire via Yahoo! Finance)
WALTHAM, Mass.----Oscient Pharmaceuticals Corporation today announced preliminary revenue for the first quarter of 2007. The Company expects to record total revenues of approximately $23 million in the first quarter of 2007, compared to $11.0 million in total revenues in the first quarter of 2006, prior to the acquisition of ANTARA capsules.